StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) KPIs and segments

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.22−0.16 (-11.59%)

Close on Nov 17, 2026Market cap $27.65MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BioHarvest Sciences's business

BioHarvest Sciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
FY2025
FY2024
FY2023
Entity-wide($M)
34.525.212.7
Products($M)
32.624.912.7
North America($M)
30.623.010.9
Israel($M)
3.922.181.81
CDMO Services($M)
1.880.280
Products($M)
19.213.85.63
CDMO Services($M)
1.300.100
United States($M)
0.08-0.240.14
Canada($M)
-4.51-7.54-4.86
Israel($M)
-6.63-5.13-7.85

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-03-31.

See a number that looks wrong?